Found: 120
Select item for more details and to access through your institution.
Insulin-Induced Distant Site Lipoatrophy.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Luseogliflozin preserves the pancreatic beta-cell mass and function in db/db mice by improving mitochondrial function.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-13888-6
- By:
- Publication type:
- Article
Urethral injury related to peri‐urethral abscess as a complication of self‐catheterization in an older patient with type 2 diabetes.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
The agreement between measured HbA1c and optimized target HbA1c based on the Dementia Assessment Sheet for Community‐based Integrated Care System 8‐items (DASC‐8): A cross‐sectional study of elderly patients with diabetes.
- Published in:
- Geriatrics & Gerontology International, 2022, v. 22, n. 8, p. 560, doi. 10.1111/ggi.14415
- By:
- Publication type:
- Article
Effect of Switching to Once-Weekly Semaglutide on Non-Alcoholic Fatty Liver Disease: The SWITCH-SEMA 1 Subanalysis.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 8, p. 2163, doi. 10.3390/pharmaceutics15082163
- By:
- Publication type:
- Article
Favorable Effect of Pemafibrate on Insulin Resistance and β-Cell Function in Subjects with Type 2 Diabetes and Hypertriglyceridemia: A Subanalysis of the PARM-T2D Study.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 7, p. 1838, doi. 10.3390/pharmaceutics15071838
- By:
- Publication type:
- Article
Definitive Diagnosis of Pancreatic Carcinoma with Percutaneous Fine Needle Aspiration Biopsy Under Ultrasonic Guidance.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1979, v. 71, n. 5, p. 469
- By:
- Publication type:
- Article
Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Pancreatic β-Cell Mass and Function.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 9, p. 5104, doi. 10.3390/ijms23095104
- By:
- Publication type:
- Article
Lessons from Mouse Models of High-Fat Diet-Induced NAFLD.
- Published in:
- International Journal of Molecular Sciences, 2013, v. 14, n. 11, p. 21240, doi. 10.3390/ijms141121240
- By:
- Publication type:
- Article
Glucokinase and IRS-2 are required for compensatory β cell hyperplasia in response to high-fat diet--induced insulin resistance.
- Published in:
- Journal of Clinical Investigation, 2007, v. 117, n. 1, p. 246, doi. 10.1172/JCI17645
- By:
- Publication type:
- Article
Circulating Neutrophil Extracellular Trap Levels in Well-Controlled Type 2 Diabetes and Pathway Involved in Their Formation Induced by High-Dose Glucose.
- Published in:
- Pathobiology, 2016, v. 83, n. 5, p. 243, doi. 10.1159/000444881
- By:
- Publication type:
- Article
A comparative study of the effects of imeglimin add‐on or metformin dose escalation on glycaemic variability in subjects with type 2 diabetes treated with low‐dose metformin (MEGMI‐CGM study).
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3471, doi. 10.1111/dom.15639
- By:
- Publication type:
- Article
Glycaemic control efficacy of switching from dipeptidyl peptidase‐4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open‐label, parallel‐group comparison study (SWITCH‐SEMA 2 study)
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 3, p. 961, doi. 10.1111/dom.15393
- By:
- Publication type:
- Article
Inverse association between glucose variability and body fat in type 2 diabetes with impaired endogenous insulin secretion assessed using continuous glucose monitoring: A prospective observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 1883, doi. 10.1111/dom.15049
- By:
- Publication type:
- Article
Improvement of glycaemic control and treatment satisfaction by switching from liraglutide or dulaglutide to subcutaneous semaglutide in patients with type 2 diabetes: A multicentre, prospective, randomized, open‐label, parallel‐group comparison study (SWITCH‐SEMA 1 study)
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1503, doi. 10.1111/dom.14998
- By:
- Publication type:
- Article
Glucokinase activation leads to an unsustained hypoglycaemic effect with hepatic triglyceride accumulation in db/db mice.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 3, p. 391, doi. 10.1111/dom.14586
- By:
- Publication type:
- Article
Glucokinase activation or inactivation: Which will lead to the treatment of type 2 diabetes?
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2199, doi. 10.1111/dom.14459
- By:
- Publication type:
- Article
Favourable effect of the sodium‐glucose co‐transporter‐2 inhibitor canagliflozin plus the dipeptidyl peptidase‐4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open‐label, prospective, randomized, parallel‐group comparison trial (the CALMER study)
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 3, p. 458, doi. 10.1111/dom.13879
- By:
- Publication type:
- Article
Effect of switching from pioglitazone to the sodium glucose co‐transporter‐2 inhibitor dapagliflozin on body weight and metabolism‐related factors in patients with type 2 diabetes mellitus: An open‐label, prospective, randomized, parallel‐group comparison trial
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 710, doi. 10.1111/dom.13557
- By:
- Publication type:
- Article
Direct visualization of glucagon‐like peptide‐1 secretion by fluorescent fusion proteins.
- Published in:
- Journal of Diabetes Investigation, 2022, v. 13, n. 7, p. 1134, doi. 10.1111/jdi.13800
- By:
- Publication type:
- Article
Impaired insulin secretion and related factors in East Asian individuals.
- Published in:
- Journal of Diabetes Investigation, 2022, v. 13, n. 2, p. 233, doi. 10.1111/jdi.13650
- By:
- Publication type:
- Article
Dipeptidyl peptidase‐4 inhibitor might exacerbate Graves' disease: A multicenter observational case–control study.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 11, p. 1978, doi. 10.1111/jdi.13578
- By:
- Publication type:
- Article
Glucokinase is required for high‐starch diet‐induced β‐cell mass expansion in mice.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 9, p. 1545, doi. 10.1111/jdi.13532
- By:
- Publication type:
- Article
Favorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 7, p. 1272, doi. 10.1111/jdi.13457
- By:
- Publication type:
- Article
Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 8, p. 1417, doi. 10.1111/jdi.13498
- By:
- Publication type:
- Article
Impact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients with type 2 diabetes treated with canagliflozin plus teneligliptin.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 8, p. 1395, doi. 10.1111/jdi.13479
- By:
- Publication type:
- Article
Beneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulators in postmenopausal women with type 2 diabetes and osteopenia/osteoporosis.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 7, p. 1293, doi. 10.1111/jdi.13458
- By:
- Publication type:
- Article
Impaired insulin secretion predicting unstable glycemic variability and time below range in type 2 diabetes patients regardless of glycated hemoglobin or diabetes treatment.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 5, p. 738, doi. 10.1111/jdi.13426
- By:
- Publication type:
- Article
Combination of alcohol and glucose consumption as a risk to induce reactive hypoglycemia.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 4, p. 651, doi. 10.1111/jdi.13375
- By:
- Publication type:
- Article
Sodium–glucose cotransporter 2 inhibitors reduce day‐to‐day glucose variability in patients with type 1 diabetes.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 2, p. 176, doi. 10.1111/jdi.13335
- By:
- Publication type:
- Article
Inverse correlation between serum high‐molecular‐weight adiponectin and proinsulin level in a Japanese population: The Dynamics of Lifestyle and Neighborhood Community on Health Study.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 1, p. 63, doi. 10.1111/jdi.13323
- By:
- Publication type:
- Article
Correlation between serum proinsulin levels and fatty liver: The Dynamics of Lifestyle and Neighborhood Community on Health Study Health Study.
- Published in:
- Journal of Diabetes Investigation, 2020, v. 11, n. 4, p. 964, doi. 10.1111/jdi.13221
- By:
- Publication type:
- Article
Proinsulin is sensitive to reflect glucose intolerance.
- Published in:
- Journal of Diabetes Investigation, 2020, v. 11, n. 1, p. 75, doi. 10.1111/jdi.13106
- By:
- Publication type:
- Article
Protective effect of sodium–glucose cotransporter 2 inhibitors in patients with rapid renal function decline, stage G3 or G4 chronic kidney disease and type 2 diabetes.
- Published in:
- Journal of Diabetes Investigation, 2019, v. 10, n. 6, p. 1510, doi. 10.1111/jdi.13064
- By:
- Publication type:
- Article
Case of fulminant type 1 diabetes induced by the anti‐programmed death‐ligand 1 antibody, avelumab.
- Published in:
- Journal of Diabetes Investigation, 2019, v. 10, n. 5, p. 1385, doi. 10.1111/jdi.13022
- By:
- Publication type:
- Article
Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial.
- Published in:
- Journal of Diabetes Investigation, 2019, v. 10, n. 3, p. 699, doi. 10.1111/jdi.12906
- By:
- Publication type:
- Article
Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: A randomized controlled trial of repaglinide vs sulfonylurea.
- Published in:
- Journal of Diabetes Investigation, 2019, v. 10, n. 2, p. 367, doi. 10.1111/jdi.12889
- By:
- Publication type:
- Article
Should sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes.
- Published in:
- Journal of Diabetes Investigation, 2019, v. 10, n. 2, p. 429, doi. 10.1111/jdi.12913
- By:
- Publication type:
- Article
Serum adiponectin and insulin secretion: A direct or inverse association?
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 5, p. 1106, doi. 10.1111/jdi.12821
- By:
- Publication type:
- Article
Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy: A randomized controlled trial.
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 1, p. 119, doi. 10.1111/jdi.12654
- By:
- Publication type:
- Article
Present status of clinical deployment of glucokinase activators.
- Published in:
- Journal of Diabetes Investigation, 2015, v. 6, n. 2, p. 124, doi. 10.1111/jdi.12294
- By:
- Publication type:
- Article
Comparison of Azelnidipine and Trichlormethiazide in Japanese Type 2 Diabetic Patients with Hypertension: The COAT Randomized Controlled Trial.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0125519
- By:
- Publication type:
- Article
AMPK Is Involved in the Regulation of Incretin Receptors Expression in Pancreatic Islets under a Low Glucose Concentration
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0064633
- By:
- Publication type:
- Article
Cross‐cultural adaptation of the Chronic Illness Resources Survey in Japanese patients with diabetes.
- Published in:
- Japan Journal of Nursing Science, 2020, v. 17, n. 1, p. N.PAG, doi. 10.1111/jjns.12279
- By:
- Publication type:
- Article
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas.
- Published in:
- Pituitary, 2023, v. 26, n. 5, p. 597, doi. 10.1007/s11102-023-01350-3
- By:
- Publication type:
- Article
Lymphocytic panhypophysitis and anti-rabphilin-3A antibody with pulmonary sarcoidosis.
- Published in:
- Pituitary, 2022, v. 25, n. 2, p. 321, doi. 10.1007/s11102-021-01200-0
- By:
- Publication type:
- Article
Letter to the Editor: False Hypercortisolemia Due to Abnormal Albumin-Cortisol Binding in a Patient with Familial Dysalbuminemic Hyperthyroxinemia.
- Published in:
- 2022
- By:
- Publication type:
- Letter
The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3).
- Published in:
- Cardiovascular Diabetology, 2017, v. 16, p. 1, doi. 10.1186/s12933-017-0607-6
- By:
- Publication type:
- Article
Hoechst-tagged Fluorescein Diacetate for the Fluorescence Imaging-based Assessment of Stomatal Dynamics in Arabidopsis thaliana.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-62239-w
- By:
- Publication type:
- Article
Preferable effects of pemafibrate on liver function and fibrosis in subjects with type 2 diabetes complicated with liver damage.
- Published in:
- Diabetology & Metabolic Syndrome, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13098-023-01187-7
- By:
- Publication type:
- Article